Avian myeloblastosis virus consists of a mixture of a defective leukaemia virus and several non-defective associated avian leukosis viruses. The genomes of two of the associated avian leukosis viruses were examined in this study and were chosen because one of them, MAV-2(N), induces predominantly nephroblastoma, while the other, MAV-2(O), induces predominantly osteopetrosis. Competitive hybridization studies employing labelled virion RNA and DNA from normal and malignant tissue failed to demonstrate a difference between the genomes. However, examination of ribonuclease Tl-resistant ofigonucleotide maps revealed that MAV-2(N) RNA had five oligonucleotide fragments which were not present in the MAV-2(O) genome. Poly(A) selection of the oligonucleotides at the 3' end of the genome showed that the fragments unique to MAV-2(N) were not present at this end of the genome. These results suggest that two viruses differing in oncogenic manifestation also differ in genome composition.
The BAI strain A of avian myeloblastosis virus (AMV) consists of several non-defective lymphoid leukosis viruses and a defective leukaemogenic component (Moscovici & Vogt, 1968; Moscovici & Zanetti, 1970; Ishizaki et al., 1975) . Non-leukaemogenic myeloblastosisassociated viruses MAV-1, MAY-2, MAV-2(O) and MAV-2(N) have been isolated (Moscovici & Vogt, 1968; Smith & Moscovici, 1969; Ogura et al., 1974) . Plaque-purified MAV-2(O) induced at least 80 % incidence of osteopetrosis and 20 % nephroblastoma (Smith & Moscovici, 1969; Banes & Smith, 1977; Smith et al., 1976) , while plaque-purified MAV-2(N) induced greater than 80% incidence of nephroblastoma and less than 30% osteopetrosis in infected chickens (Watts & Smith, 1980) . Biochemical characterizations of purified MAV-2(N) and MAV-2(O) propagated in tissue culture indicated that both viruses possessed the same size 35S RNA genome, the same relative amounts of virus polypeptides, and the same kinetics of hybridization of virus RNA to DNA from virus-induced tumours (Watts, 1978; S. L. Watts et al., unpublished results) . For further analysis, we have used competitive nucleic acid hybridization and fingerprinting of RNase Tl-resistant oligonucleotides to examine genetic differences which might distinguish MAV-2(N) from MAV-2(O) and correlate with the pathological manifestations of infected chickens.
In the competition hybridization studies employed in this work, increasing amounts of unlabelled virus RNA were used as competitors in hybridization reactions between in vitro radio-iodinated virus RNA from RAV/O, MAV-2(N), MAV-2(O) and AMV, and their respective proviral sequences from uninfected and tumour tissues, in an attempt to distinguish these viruses. Hybridization was performed in reaction mixtures of 60 #l for 72 h at 68 °C for a Cot value of 4.5 x 104 mol. s/1. Reaction mixtures were assayed by resistance of labelled RNA to digestion with pancreatic RNase. MAV-2(N) and MAV-2(O) RNAs competed for approx. 85 % of the DNA in normal chick embryos which was homologous to RAV-O RNA. AMV RNA competed for approx. 80% of the RAV-O proviral sequences, yet more AMV RNA was required to give the same degree of competition as a given amount of MAV-2(N) 0022-1317/82/0000-4971 $02.00 © 1982 SGM Because of the limited sensitivity of the competition hybridization experiments, we have analysed both MAV-2(N) and MAV-2(O) RNAs by T 1 oligonucleotide fingerprinting to determine if any sequence differences can be detected between these two viruses. The oligonucleotide patterns of MAV-2(N) (cloned by plaque purification four times) and MAV-2(O) (cloned by plaque purification three times) RNAs were found to be distinguishable (Fig. 1) . Furthermore, these differences were consistent for two plaquepurified clones of MAV-2(N) and several clones of MAV-2(O) purified from infected chicken serum, indicating that these differences were not a function of independent virus passage but of the characteristic biological type of virus. Pancreatic RNase digestion was used to determine the composition of all of the large oligonucleotides observed (Table 1) . Twenty-six oligonucleotides of MAV-2(N) RNA and MAV-2(O) RNA were analysed and shown to be represented only once in the genome. Oligonucleotides N1, N17, N18, N19 and N20 were specific for MAV-2(N), while oligonucleotides O17, O18, O19 and 020 were specific for MAV-2(O). Composition and molar yield values for MAV-2(N) RNA oligonucleotides are summarized in Table 1 . Two oligonucleotides of interest could not be isolated in pure form; therefore, their nucleotide composition was not determined. Only oligonucleotides 15 and 22 were present in greater than molar yield relative to the yield of oligonucleotide 2, the capped oligonucleotide at the 5' end of the molecule.
The oligonucleotides of MAV-2(N) RNA not present in MAV-2(O) RNA are of particular interest to our determination of the genetic and pathological distinctions between MAV-2(N), MAV-2(O) and AMV. The 3' terminus of the retrovirus genome has been associated with sequences distinguishing types of avian leukosis viruses (Tsichlis & Coffin, 1980) and with promoter functions essential to avian leukosis virus oncogenicity (Neel et al., 1981) . Thus, an experiment was performed to determine whether the MAV-2(N)-specific oligonucleotides were located at the 3' terminus of the genome. MAV-2(N) RNA was subjected to limited hydrolysis with Na2CO 3 to fragment the RNA into pieces of less than 400 nucleotides. Poly(A)-containing fragments were selected using oligo(dT)-cellulose, and the fragments were subjected to RNase T 1 digestion and fingerprint analysis (Coffin & Billeter, 1976) . None of the MAV-2(N)-specific oligonucleotides was evident on this fingerprint of 3' terminal (Beemon et al., 1976) . RNase Tl-resistant oligonucleotides were separated by two dimensional polyacrylamide get electrophoresis using a first dimension gel of 10% Fig. 1 were excised from gels and assayed for radioactivity by scintillation counting using the Cerenkov method. The excised nucleotides were eluted from the gel by incubation for 4 h at 37 °C in 0.5 M-ammonium acetate, 0.02 M-magnesium acetate, 0.1 mM-EDTA, 0.1% (w/v) SDS, pH 7.2. The composition of the nucleotides was determined by digestion with 2 gg pancreatic RNase for 1 h at 37 °C and separation of the digestion products by high voltage electrophoresis on DEAE paper in pyridine-acetic acid pH 3.5 (Barrell, 1971) . Y denotes an undetermined pyrimidine. MAV-2(N) oligonucleotides 2 to 16 and 21 to 26 were identical in composition to MAV-2(O) oligonucleotides; N1, N17, N18, N19 and N20 were specific for MAV-2(N). Determination of the nucleotide length of the oligonucleotides allowed quantification of the molar yield of each oligonucleotide relative to the yield of the 5' terminal capped oligonucleotide as calculated from the radioactivity contained in eacb gel section.
"~ ND, Not determined.
oligonucleotides, although oligonucleotides 11, 24, 21 and 15 which have been mapped at the 3' terminus of MAV-2(O) RNA (Schmidt et al., 1982) were present. Therefore, the T~ oligonucleotides unique to MAV-2(N) do not appear to be present within the U 3 region of unique sequences in the large terminally redundant region found only at the 3' terminus of the virus genome. The results presented in this paper establish that MAV-2(N) and MAV-2(O) are closely related but genetically distinct lymphoid leukosis viruses present in stocks of AMV. Further nucleic acid analyses will clarify the genetic uniqueness of the MAV-2(N)genome and provide insight into the origin of the different oncogenic potentials of these viruses.
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